Human Kappa and Lambda Free Light Chain Control - Sekisui Diagnostics
Criteria for Presumptive Diagnosis of IgD Multiple Myeloma
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
Next generation free light chain assay - Clinical Laboratory int.
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
Comparison of the distribution of kappa and lambda free light chains... | Download Scientific Diagram
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument - ScienceDirect
IJMS | Free Full-Text | Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma | Blood Cancer Journal
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
FLC Why choose the Sebia Free Light Chain (FLC) assay?
Discrepancy in serum free light chain analysis compared with serum... | Download Scientific Diagram
Table 3 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern | Fluids and Barriers of the CNS
Sebia And Abingdon Health Sign Exclusive Global Distribution Agreement | Medical Product Outsourcing
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay